# RYBELSUS
> **NDA213182** · New Drug Application · Sponsor: NOVO NORDISK INC · Approved 2020-01-16
## Drug
- **FDA Application Number:** NDA213182
- **Application type:** New Drug Application
- **Brand name:** RYBELSUS
- **Generic name:** Semaglutide
- **Active ingredients:** SEMAGLUTIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** NOVO NORDISK INC
- **First approval:** 2020-01-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213182)
---
*AI Analytics · CC0 1.0*